The FDA has signed off Sight Sciences Inc's clinical study to assess investigational higher volume OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with ...
网页链接The FDA has signed off Sight Sciences Inc's clinical study to assess investigational higher volume OMNI device to perform canal viscodilation alone to lower intraocular pressure (IOP) in adults with ...
网页链接
精彩评论